Trepo - Selaus tekijän mukaan "Azmeraye, Binyam Moges"

Viitteet 1-2 / 2

    • Factors Associated with Uptake of Routine Measles-Containing Vaccine Doses among Young Children, Oromia Regional State, Ethiopia, 2021 

      Woyessa, Abyot Bekele; Shah, Monica P.; Azmeraye, Binyam Moges; Pan, Jeff; Lisanwork, Leuel; Yimer, Getnet; Wang, Shu Hua; Nuorti, J. Pekka; Artama, Miia; Matanock, Almea M.; An, Qian; Samuel, Paulos; Tolera, Bekana; Kenate, Birhanu; Bekele, Abebe; Deti, Tesfaye; Wako, Getachew; Shiferaw, Amsalu; Tefera, Yohannes Lakew; Kokebie, Melkamu Ayalew; Anbessie, Tatek Bogale; Wubie, Habtamu Teklie; Wallace, Aaron; Sugerman, Ciara E. (07 / 2024)
      article
      Recommended vaccination at nine months of age with the measles-containing vaccine (MCV1) has been part of Ethiopia’s routine immunization program since 1980. A second dose of MCV (MCV2) was introduced in 2019 for children ...

    • Timeliness of measles vaccination in selected districts of Oromia Region, Ethiopia – 2021 

      Shah, Monica P.; Woyessa, Abyot Bekele; Matanock, Almea M.; Azmeraye, Binyam Moges; Lisanwork, Leuel; Yimer, Getnet; Wang, Shu Hua; Pan, Xueliang; Samuel, Paulos; Tolera, Bekana; Sori, Birhanu Kenate; Bekele, Abebe; Deti, Tesfaye; Wako, Getachew; Shiferaw, Amsalu; Tefera, Yohannes Lakew; Kokebie, Melkamu Ayalew; Anbessie, Tatek Bogale; Wubie, Habtamu Teklie; An, Qian; Wallace, Aaron; Sugerman, Ciara E. (10 / 2026)
      article
      Background Delays in vaccination with the first/second dose of measles-containing vaccine (MCV1, MCV2) increases risk of measles transmission. MCV2 was added to Ethiopia's routine immunization schedule in 2019, administered ...